Gain Therapeutics, Inc.GANXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-18.90M
↓ 86% below average
Average (6y)
$-10.13M
Historical baseline
Range
High:$-752501.00
Low:$-18.90M
CAGR
+71.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-18.90M | -0.1% |
| 2023 | $-18.88M | -27.5% |
| 2022 | $-14.81M | -18.9% |
| 2021 | $-12.46M | -282.1% |
| 2020 | $-3.26M | -73.3% |
| 2019 | $-1.88M | -150.1% |
| 2018 | $-752501.00 | - |